Litigation Details for Amyris, Inc. (Bankr. D. Del. 2023)
✉ Email this page to a colleague
Amyris, Inc. (Bankr. D. Del. 2023)
| Docket | ⤷ Try a Trial | Date Filed | 2023-08-09 |
| Court | United States Bankruptcy Court, D. Delaware | Date Terminated | |
| Cause | Assigned To | Thomas M. Horan | |
| Jury Demand | Referred To | ||
| Patents | 10,533,041; 7,872,050; 7,897,050; 8,008,006; 8,546,136; 9,000,011; 9,701,971 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Amyris, Inc.
The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial and ⤷ Try a Trial .
Biologic Drugs cited in Amyris, Inc.
The biologic drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Details for Amyris, Inc. (Bankr. D. Del. 2023)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2024-01-22 | 1177 | Exhibit 3 | US 13/430,322 US 8,546,136 2013-10-01 2029-11-19 …Notes: The AM-6400 patent family is co-owned by Amyris and Total; all other AM patent families are owned…Sciences LLC) UC patent families are in-licensed from University of California GV patent families are co-owned…Givaudan and Amyris KU patent families are co-owned by Kuraray and Amyris KE patent families are in-licensed… Page 2 of 51 Patent Portfolio (owned, co-owned, or licensed by Amyris | External link to document |
| 2023-11-01 | 663 | Exhibit A | $10,533.41 TOTAL CURRENT CHARGES … $10,533.41 Case 23-11131-TMH Doc… $10,533.41 Amyris, Inc. 9… discussion concerning patent treatment. 08/21/2023 HCK AA Conference…negotiations 08/15/2023 DG EC Call with Patent counsel from Goodwin re: 0.50 1,550.00 | External link to document |
| 2023-12-01 | 805 | Exhibit A | 31/2023 $1,275,515.75 $10,533.41 $1,286,049.16 134981 …2023 GIG BL Review Lavvan complaint re patent 0.70 1,325.00 $927.50 | External link to document |
| 2023-12-01 | 809 | Exhibit B - Disclosure Statement | Non-Current Assets (IP) (8) 8.6 5.0 20.0 58% … Assets (IP) (8) 8.6 5.0 20.0 58% …, as applicable, entered into various security, patent, copyright, and trademark security agreements (…-07386-JPO) in which Lavvan asserted claims for patent infringement and misappropriation of trade secrets | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
